• Suppliers
  • External Access
Media

Gestamp appoints Carmen de Pablo as Chief Financial Officer

Carmen de Pablo, CFO of Gestamp.
Carmen de Pablo, CFO of Gestamp.

Ms. De Pablo was the Director of Corporate Development & Investor Relations and led the company’s IPO process

19.12.2019

Gestamp, the multinational company specialized in the design, development and manufacture of highly engineered metal components for the automotive industry, has appointed Carmen de Pablo as the company’s new Chief Financial Officer (CFO). She was previously the Director of Corporate Development and Investor Relations. Her appointment has been approved by the Nomination and Compensation Committee as well as by the Board of Directors of Gestamp.

Ms. De Pablo will succeed Miguel Escrig who will step down from his position as CFO, as mutually agreed with the company. Mr. Escrig will continue to work with the group as external financial advisor, a new career path that he has decided to pursue after almost two years at Gestamp. During his tenure he has contributed to the improvement of overall financial management, financing activities and working capital.

Carmen de Pablo joined Gestamp’s Office of the Chairman in 2013. Amongst other projects, she led the company’s IPO process, which was completed in April 2017, and since then she has been the Director of Investor Relations. In 2018 she assumed further responsibilities as Director of Corporate Development including functions such as M&A, international financing and analysis of Gestamp’s key global projects and investments. Following this announcement Ms. De Pablo will join Gestamp’s Management Committee.

Ms. De Pablo holds a Bachelor of Business Administration from CUNEF and an MBA from Tuck Business School at Dartmouth, USA. She began her career at EY in 1995 and worked at JP Morgan, Lehman Brothers, McKinsey and lastly at Morgan Stanley, where she was an Executive Director in the Investment Banking Division for more than 12 years.

Documentation

zip
5.8 MB

Gallery

Gestamp in the face of COVID-19